Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly mifepristone 50 mg contraception study
ISRCTN29802260Phase 3Terminated
- Sponsor
- Women on Waves
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of mifepristone, sponsored by Women on Waves. Primary endpoints: Occurrence of pregnancy during treatment, Endometrial changes and 1 more. Started Oct 2023; status: terminated.
02
Drugs
mifepristone
Beyond the preview
Go deeper on ISRCTN29802260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN29802260.